| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | $1.0B | $1.0B | $1.0B | $1.0B | $0.1B | $0.0B | $0.0B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | $0.0B |
| SG&A Expense | — | $0.4B | $0.4B | $0.4B | $0.4B | $0.1B | $0.0B | $0.0B |
| Operating Income | $-0.0B | $0.1B | $0.1B | $-0.0B | $-0.1B | $-0.1B | $-0.0B | $-0.0B |
| Net Income | $-3.2B | $0.9B | $0.7B | $1.3B | $0.7B | $0.4B | $0.1B | $0.0B |
| EPS (Basic) | — | $6.08 | $4.71 | $8.01 | $3.97 | $2.18 | $0.51 | $0.08 |
| EPS (Diluted) | — | $6.08 | $4.68 | $7.96 | $3.93 | $2.17 | $0.50 | $0.08 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $8.8B | $16.7B | $15.6B | $15.1B | $17.0B | $21.4B | $12.3B | $12.1B |
| Current Assets | $0.1B | $0.4B | $0.4B | $0.7B | $0.5B | $1.8B | $0.1B | $0.1B |
| Cash & Equivalents | $0.1B | $0.2B | $0.2B | $0.4B | $0.2B | $1.4B | $0.0B | $0.1B |
| Total Liabilities | $3.1B | $6.9B | $6.6B | $6.6B | $6.8B | $7.9B | $1.6B | $1.5B |
| Current Liabilities | $1.0B | $0.2B | $0.2B | $1.7B | $0.6B | $0.6B | $0.0B | $0.0B |
| Stockholders' Equity | $5.7B | $9.8B | $9.0B | $8.5B | $10.1B | $13.5B | $10.7B | $10.6B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | — | $0.1B | $0.0B | $-0.1B | $0.0B | $-0.1B | $-0.0B | $-0.0B |
| Investing Cash Flow | — | $0.1B | $0.1B | $3.0B | $4.1B | $0.6B | $-0.0B | $-0.0B |
| Capital Expenditures | — | $0.2B | $0.2B | $0.2B | $0.1B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | — | $-0.2B | $-0.4B | $-2.8B | $-5.3B | $0.9B | $0.0B | $0.0B |